Lipoprotein deficiency. E78.6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM E78.6 became effective on October 1, 2018.
Hypoalphalipoproteinemia is a high-density lipoprotein deficiency, inherited in an autosomal dominant manner.
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code E78.6. Click on any term below to browse the alphabetical index.
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 272.5 was previously used, E78.6 is the appropriate modern ICD10 code.
Other lipoprotein metabolism disorders 1 E78.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM E78.89 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of E78.89 - other international versions of ICD-10 E78.89 may differ.
The 2021 edition of ICD-10-CM E78.89 became effective on October 1, 2020.
E78.6 is a billable diagnosis code used to specify a medical diagnosis of lipoprotein deficiency. The code E78.6 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
HYPOALPHALIPOPROTEINEMIAS-. conditions with abnormally low levels of alpha lipoproteins high density lipoproteins in the blood. hypoalphalipoproteinemia can be associated with mutations in genes encoding apolipoprotein a i; lecithin cholesterol acyltransferase; and atp binding cassette transporters.
Abetalipoproteinemia is an inherited disorder that impairs the normal absorption of fats and certain vitamins from the diet. Many of the signs and symptoms of abetalipoproteinemia result from a severe shortage (deficiency) of fat-soluble vitamins (vitamins A, E, and K). The signs and symptoms of this condition primarily affect the gastrointestinal system, eyes, nervous system, and blood.
Individuals with abetalipoproteinemia usually have a low number of red blood cells (anemia) with abnormally star-shaped red blood cells (acanthocytosis) and have difficulty forming blood clots, which can cause abnormal bleeding. In some cases, a condition called fatty liver develops, which can cause liver damage.
Familial hypobetalipoproteinemia Familial hypobetalipoproteinemia (FHBL) is a disorder that impairs the body's ability to absorb and transport fats. This condition is characterized by low levels of a fat-like substance called cholesterol in the blood.
Lipid metabolism disorders, such as Gaucher disease and Tay-Sachs disease, involve lipids. Lipids are fats or fat-like substances. They include oils, fatty acids, waxes, and cholesterol. If you have one of these disorders, you may not have enough enzymes to break down lipids. Or the enzymes may not work properly and your body can't convert the fats into energy. They cause a harmful amount of lipids to build up in your body. Over time, that can damage your cells and tissues, especially in the brain, peripheral nervous system, liver, spleen, and bone marrow. Many of these disorders can be very serious, or sometimes even fatal.
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)
Disorders of lipoprotein metabolism and other lipidemias 1 E78 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 2 The 2021 edition of ICD-10-CM E78 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of E78 - other international versions of ICD-10 E78 may differ.
E78 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.